Acquisition of 74.97% Stake in Korea Union Pharmaceutical for 30 Billion Won via Third-Party Allotment
Decision to acquire shares of another corporation: 60,000,000 shares (74.97% stake) of Korea Union Pharmaceutical for 30 billion won via third-party allotment (cash acquisition).
Purpose: Expand production capacity and business through securing manufacturing facilities.
Target financials (FY2025): Total assets 45.8 billion won, total liabilities 68.7 billion won, total equity -22.9 billion won (capital impairment), revenue 36.4 billion won, net loss 30.8 billion won, audit opinion 'disclaimer'.
Acquisition date may change depending on rehabilitation plan and court approval; correction disclosure to follow.
KOSPI Filing Information
Decision on Acquisition of Stocks and Investment Securities of Other Corporations
Company: BUKWANG PHARMACEUTICAL IND (003000)
Submission: BUKWANG PHARMACEUTICAL IND CO.,LTD
Under KRX KOSPI Market Division, Amended (Refer to related filing)